About Adis R&D Insight...
Adis R&D Insight is compiled from information collected from many sources. The primary sources are:
- direct contact with companies involved with research and development
- information collected from drug and therapeutic literature published in over 2,300 medical and biomedical journals
- attendance at international meetings and conferences
- company annual reports, news services, press releases, and licensed Lehman Brothers' PharmaPipelines data
The results are detailed summaries, termed "Profiles," of drugs under active research and development by the international pharmaceutical industry.
Sharon might be interested in some of this additional information.
Additional key points about this file are:
- Includes generic name, synonyms and brand names, developing companies, development phases by indication and country, adverse events, pharmacology, pharmacokinetics, pharmacodynamics, therapeutic trials, development history, and licensed forecast information from Lehman Brothers.
- Has its own unique therapeutic value ratings based on the product candidate's potential at each testing stage (preclinical, phase I, etc.) and on licensed forecasts from the stockbrokers Lehman Brothers. Ratings are specific to a particular indication and/or route of administration (or dosage form).
- Adis profiles are backed by over 10,000 evaluated Adis scientific summaries and 63,000 bibliographic references, including references to Web resources.
- New drugs are added to the database weekly as soon as they are identified as being in active development and the profiles created are continually updated as new information becomes available.
- Clinical data summaries identify route of administration, dosage regimens tested, and comparator products significant for competitive market positioning within the drug class.
- Monitors target markets not covered in other pipeline directories. Consistent, coordinated indexing of indications with stage of development and target markets.
- Contains WHO ATC Codes and EPhMRA therapeutic codes (some variation from those in File 128)
- Covers 1986 to the present for products in active development.
- Patent expiry coverage is available in this database.
Go to the next page.
4-2
